These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32463770)

  • 21. Costs of implementing pharmaceutical care in community pharmacies.
    Norwood GJ; Sleath BL; Caiola SM; Lien T
    J Am Pharm Assoc (Wash); 1998; 38(6):755-61. PubMed ID: 9861794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community pharmacy strives for continuity of care.
    Sellers JA
    Am J Health Syst Pharm; 1998 Apr; 55(7):635-7. PubMed ID: 9558415
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of a community pharmacy disaster preparedness manual.
    Noe B; Smith A
    J Am Pharm Assoc (2003); 2013; 53(4):432-7. PubMed ID: 23892819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the implementation of a novel optimizing care model in the community pharmacy setting.
    Hohmeier KC; Desselle SP
    J Am Pharm Assoc (2003); 2019; 59(3):310-318. PubMed ID: 30940516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012.
    Schommer JC; Yusuf AA; Hadsall RS
    Res Social Adm Pharm; 2014; 10(1):217-31. PubMed ID: 23669250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacy-based referral program to assist low-income Medicare beneficiaries.
    Hastings TJ; Hohmann LA; Neal J; Westrick SC
    J Am Pharm Assoc (2003); 2019; 59(3):416-422. PubMed ID: 30826302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organisational and extraorganisational determinants of volume of service delivery by English community pharmacies: a cross-sectional survey and secondary data analysis.
    Hann M; Schafheutle EI; Bradley F; Elvey R; Wagner A; Halsall D; Hassell K; Jacobs S
    BMJ Open; 2017 Oct; 7(10):e017843. PubMed ID: 29018074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing pharmacy's image.
    Brown PC
    Am Pharm; 1989 Nov; NS29(11):6. PubMed ID: 2816727
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacy's current economic problems.
    McDONNELL JN
    Am J Pharm Sci Support Public Health; 1953 Aug; 125(8):265-77. PubMed ID: 13080427
    [No Abstract]   [Full Text] [Related]  

  • 31. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
    Maulavizada H; Emmerton L; Hattingh HL
    BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of strategic planning on product marketing and health service orientation of community pharmacies-A national survey in Finland.
    Jokinen L; Puumalainen I; Airaksinen M
    Health Policy; 2019 May; 123(5):462-467. PubMed ID: 30808534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a community pharmacy workflow process to identify and follow up with prescription abandonment.
    Chancy P; Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S129-S135. PubMed ID: 31231004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication synchronization adoption and pharmacy performance.
    Renfro CP; Turner K; Seeto J; Ferreri SP
    Res Social Adm Pharm; 2021 Aug; 17(8):1496-1500. PubMed ID: 33234452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is a third class of drugs in pharmacy's future?
    Martin S
    Am Pharm; 1991 Apr; NS31(4):36-40. PubMed ID: 2038961
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.
    MacKeigan LD; Ijaz N; Bojarski EA; Dolovich L
    Res Social Adm Pharm; 2017; 13(5):947-958. PubMed ID: 28462792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independently owned pharmacy closures in rural America.
    Klepser D; Xu L; Ullrich F; Mueller K
    Rural Policy Brief; 2008 Jul; (2008 2):1-4. PubMed ID: 19688903
    [No Abstract]   [Full Text] [Related]  

  • 40. Demographic and economic characteristics associated with sole county pharmacy closures, 2006-2010.
    Weigel P; Ullrich F; Mueller K; ;
    Rural Policy Brief; 2013 Nov; (2013 15):1-4. PubMed ID: 25399463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.